Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Innoviz Technologies (INVZW) Other financing activities (2020 - 2025)

Historic Other financing activities for Innoviz Technologies (INVZW) over the last 6 years, with Q3 2025 value amounting to $866.3 million.

  • Innoviz Technologies' Other financing activities rose 773.25% to $866.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $866.3 million, marking a year-over-year increase of 773.25%. This contributed to the annual value of $809.0 million for FY2024, which is 258.66% up from last year.
  • According to the latest figures from Q3 2025, Innoviz Technologies' Other financing activities is $866.3 million, which was up 773.25% from $854.3 million recorded in Q2 2025.
  • Innoviz Technologies' Other financing activities' 5-year high stood at $866.3 million during Q3 2025, with a 5-year trough of $2000.0 in Q1 2021.
  • For the 5-year period, Innoviz Technologies' Other financing activities averaged around $714.7 million, with its median value being $714.5 million (2023).
  • Its Other financing activities has fluctuated over the past 5 years, first surged by 3442960000.0% in 2022, then soared by 258.66% in 2024.
  • Quarter analysis of 5 years shows Innoviz Technologies' Other financing activities stood at $683.8 million in 2021, then rose by 2.94% to $703.9 million in 2022, then grew by 12.04% to $788.6 million in 2023, then grew by 2.59% to $809.0 million in 2024, then grew by 7.08% to $866.3 million in 2025.
  • Its Other financing activities was $866.3 million in Q3 2025, compared to $854.3 million in Q2 2025 and $850.5 million in Q1 2025.